Related references
Note: Only part of the references are listed.Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Mark J. Truty et al.
ANNALS OF SURGERY (2021)
MRI vs. CT for the Detection of Liver Metastases in Patients With Pancreatic Carcinoma: A Comparative Diagnostic Test Accuracy Systematic Review and Meta-Analysis
Mostafa Alabousi et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2021)
Arterial, but Not Venous, Reconstruction Increases 30-Day Morbidity and Mortality in Pancreaticoduodenectomy
Sara L. Zettervall et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Venous resection for adenocarcinoma of head of pancreas: Does extent of portal vein resection affect outcomes?
Sundeep Jain et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).
Davendra Sohal et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients
B. Kurlinkus et al.
SCANDINAVIAN JOURNAL OF SURGERY (2020)
The Impact on Survival and Morbidity of Portal-Mesenteric Resection During Pancreaticoduodenectomy for Pancreatic Head Adenocarcinoma: A Systematic Review and Meta-Analysis of Comparative Studies
Alessandro Fancellu et al.
CANCERS (2020)
Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
Christelle Bouchart et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05).
Michiaki Unno et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing
Andrew J. Lee et al.
HPB (2019)
Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
June S. Peng et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2019)
Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a prospective multicenter study
Eran van Veldhuisen et al.
HPB (2019)
O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes
M Reni et al.
ANNALS OF ONCOLOGY (2019)
The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis
Cheng Peng et al.
BMC SURGERY (2019)
Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis
Motokazu Sugimoto et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy
Thomas Hank et al.
JAMA SURGERY (2019)
Venous resection during pancreatectomy for pancreatic cancer: a systematic review
Xiaobo Wang et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?
Jin He et al.
ANNALS OF SURGERY (2018)
Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival
Fritz Klein et al.
EJSO (2018)
Assessment of response to chemotherapy in pancreatic ductal adenocarcinoma: Comparison between diffusion-weighted MR quantitative parameters and RECIST
Maria Antonietta Bali et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement
Yuichi Hosokawa et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma
Brandon C. Chapman et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Venous thrombosis following pancreaticoduodenectomy with venous resection
Somala Mohammed et al.
JOURNAL OF SURGICAL RESEARCH (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy
Marc Zins et al.
RADIOLOGY (2018)
Challenges in diagnosis of pancreatic cancer
Lulu Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Preoperative prediction of peripancreatic vein invasion by pancreatic head cancer
Yi-Nan Shen et al.
CANCER IMAGING (2018)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration
Giuseppe Malleo et al.
PANCREATOLOGY (2017)
Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society
Suguru Yamada et al.
SURGERY (2017)
Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters
Pietro Addeo et al.
SURGERY (2017)
Meta-analysis and cost effective analysis of portal-superior mesenteric vein resection during pancreatoduodenectomy: Impact on margin status and survival
Richard Bell et al.
SURGICAL ONCOLOGY-OXFORD (2017)
Pancreatoduodenectomy with venous or arterial resection: a NSQIP propensity score analysis
Joal D. Beane et al.
HPB (2017)
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma Updates From a French Prospective Multicenter Study
Jean Robert Delpero et al.
ANNALS OF SURGERY (2017)
Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer
R. Ravikumar et al.
BRITISH JOURNAL OF SURGERY (2017)
Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy
D. Kleive et al.
BRITISH JOURNAL OF SURGERY (2017)
The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis
Stephan Schorn et al.
CANCER TREATMENT REVIEWS (2017)
Pancreatic Cancer Surgery The New R-status Counts
Oliver Strobel et al.
ANNALS OF SURGERY (2017)
Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma
F. Giovinazzo et al.
BRITISH JOURNAL OF SURGERY (2016)
Frozen Section Interpretation of Pancreatic Margins: Subspecialized Gastrointestinal Pathologists Versus General Pathologists
Yong-Jun Liu et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2016)
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival
Sun Mi Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection
Franz Mierke et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
Steffi J. Rombouts et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma
Alexandra M. Roch et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Justifying vein resection with pancreatoduodenectomy
Savio G. Barreto et al.
LANCET ONCOLOGY (2016)
Parietal Peritoneum as an Autologous Substitute for Venous Reconstruction in Hepatopancreatobiliary Surgery
Safi Dokmak et al.
ANNALS OF SURGERY (2015)
Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Fran‡aise de Chirurgie
Jean Robert Delpero et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma
Y. Murakami et al.
BRITISH JOURNAL OF SURGERY (2015)
Meta-analysis of radical resection rates and margin assessment in pancreatic cancer
M. D. Chandrasegaram et al.
BRITISH JOURNAL OF SURGERY (2015)
Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion
Wei-Lin Wang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)
Perioperative and Long-Term Outcome after Standard Pancreaticoduodenectomy, Additional Portal Vein and Multivisceral Resection for Pancreatic Head Cancer
Birte Kulemann et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates
Tsutomu Fujii et al.
SURGERY (2015)
New challenges in perioperative management of pancreatic cancer
Francesco Puleo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience
Christoph W. Michalski et al.
BMC SURGERY (2015)
Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma
Jaehong Jeong et al.
ANZ JOURNAL OF SURGERY (2015)
Adverse Tumor Biology Associated with Mesenterico-Portal Vein Resection Influences Survival in Patients with Pancreatic Ductal Adenocarcinoma
F. Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis
X. Z. Yu et al.
EJSO (2014)
Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review
RenBao Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer
Hop S. Tran Cao et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Vascular resection during radical resection of pancreatic adenocarcinomas: evolution over the past 15 years
Mehdi Ouaissi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study
Reena Ravikumar et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes
Seiko Hirono et al.
LANGENBECKS ARCHIVES OF SURGERY (2014)
Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens
Jean Robert Delpero et al.
HPB (2014)
Should the Portal Vein Be Routinely Resected During Pancreaticoduodenectomy For Adenocarcinoma?
Olivier Turrini et al.
ANNALS OF SURGERY (2013)
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of Borderline Resectable Disease?
Kaitlyn J. Kelly et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma
Yoshiaki Murakami et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pancreaticoduodenectomy Combined with Vascular Resection and Reconstruction for Patients with Locally Advanced Pancreatic Cancer: A Multicenter, Retrospective Analysis
Yi Gong et al.
PLOS ONE (2013)
Resection Margins in Pancreatic Cancer
Caroline S. Verbeke
SURGICAL CLINICS OF NORTH AMERICA (2013)
Vascular Invasion in Infiltrating Ductal Adenocarcinoma of the Pancreas Can Mimic Pancreatic Intraepithelial Neoplasia: A Histopathologic Study of 209 Cases
Seung-Mo Hong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Vascular Surgery Collaboration During Pancreaticoduodenectomy With Vascular Reconstruction
Ryan S. Turley et al.
ANNALS OF VASCULAR SURGERY (2012)
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation
Jiansheng Wang et al.
CANCER (2012)
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma
Deyali Chatterjee et al.
CANCER (2012)
Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas
V. M. Banz et al.
EJSO (2012)
Clinical Significance of Portal-Superior Mesenteric Vein Resection in Pancreatoduodenectomy for Pancreatic Head Cancer
Sung-Sik Han et al.
PANCREAS (2012)
Vascular invasion in pancreatic cancer: Tumor biology or tumor topography?
Alexander Rehders et al.
SURGERY (2012)
Pancreatectomy Combined with Superior Mesenteric Vein-Portal Vein Resection for Pancreatic Cancer: A Meta-analysis
Yanming Zhou et al.
WORLD JOURNAL OF SURGERY (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Tumoral and Nontumoral Pancreas: Correlation between Quantitative Dynamic Contrast-enhanced MR Imaging and Histopathologic Parameters
Maria A. Bali et al.
RADIOLOGY (2011)
Vascular Reconstruction During Pancreatoduodenectomy for Ductal Adenocarcinoma of the Pancreas Improves Resectability but does not Achieve Cure
Mehdi Ouaissi et al.
WORLD JOURNAL OF SURGERY (2010)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
Fiona Campbell et al.
HISTOPATHOLOGY (2009)
Anatomy of the Superior Mesenteric Vein With Special Reference to the Surgical Management of First-order Branch Involvement at Pancreaticoduodenectomy
Matthew H. G. Katz et al.
ANNALS OF SURGERY (2008)
A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer
Thomas J. Howard et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
JP Neoptolemos et al.
ANNALS OF SURGERY (2001)
Share Paper
